https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
168
 
downloads
6
CITE
How to cite this poster:
Visani G, Breccia M, Piccaluga PP et al. The dose and the duration of frontline therapy with imatinib does not affect response to dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real life-based Italian multicenter retrospective study on 124 patients. F1000Posters 2010, 1:179 (poster)

The dose and the duration of frontline therapy with imatinib does not affect response to dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real life-based Italian multicenter retrospective study on 124 patients

Giuseppe Visani1, Massimo Breccia, Pier Paolo Piccaluga, Antonella Gozzini, Giorgina Specchia, Enrico Montefusco, Enrica Morra, Mario Annunziata, Luigiana Luciano, Andrea Camera, Francesco Cavazzini, Fabio Stagno, Francesco Di Raimondo, Patrizia Pregno, Francesca Pirillo, Valeria Santini, Alberto Bosi, Matteo Pacilli, Ester Pungolino, Emilio Usala, Emanuele Angelucci, Monica Crugnola, Gianni Binotto, Elena Maino, Federica Loscocco, Sara Barulli, Giuseppina Nicolini, Antonio Cuneo, Roberto Latagliata, Felicetto Ferrara, Alessandro Isidori
Published 31 Mar 2010
Author Affiliations
  • Metrics
  • 168 Views
  • 6 Downloads
Browse by related subjects
Published 31 Mar 2010

The dose and the duration of frontline therapy with imatinib does not affect response to dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real life-based Italian multicenter retrospective study on 124 patients

[version 1; not peer reviewed]

Giuseppe Visani1, Massimo Breccia, Pier Paolo Piccaluga, Antonella Gozzini, Giorgina Specchia, Enrico Montefusco, Enrica Morra, Mario Annunziata, Luigiana Luciano, Andrea Camera, Francesco Cavazzini, Fabio Stagno, Francesco Di Raimondo, Patrizia Pregno, Francesca Pirillo, Valeria Santini, Alberto Bosi, Matteo Pacilli, Ester Pungolino, Emilio Usala, Emanuele Angelucci, Monica Crugnola, Gianni Binotto, Elena Maino, Federica Loscocco, Sara Barulli, Giuseppina Nicolini, Antonio Cuneo, Roberto Latagliata, Felicetto Ferrara, Alessandro Isidori
Author Affiliations
1 Hematology and Stem Cell Transplant Center, San Salvatore Hospital, Italy
Presented at
51st American Society of Hematology Annual Meeting 2009
Abstract
Competing Interests

No relevant conflicts of interest declared.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.